Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply

Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply

<p>Abstract</p> <p>A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc.</p>

Bibliographic Details
Main Authors:	Shakur Haleema, Roberts Ian
Format:	Article
Language:	English
Published:	BMC 2009-12-01
Series:	Trials
Online Access:	http://www.trialsjournal.com/content/10/1/111

Similar Items

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
by: Rätsep Indrek, et al.
Published: (2009-12-01)

A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
by: Abda Mahmood, et al.
Published: (2017-07-01)

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
by: Dewan Yashbir, et al.
Published: (2012-06-01)

A nested randomised trial of the effect of tranexamic acid on intracranial haemorrhage and infarction in traumatic brain injury (CRASH-3 trial intracranial bleeding mechanistic study): Statistical analysis plan [version 2; peer review: 2 approved, 1 approved with reservations]
by: Abda Mahmood, et al.
Published: (2019-01-01)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial [version 1; referees: 2 approved]
by: Ian Roberts, et al.
Published: (2018-07-01)

Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial [version 2; referees: 3 approved, 1 approved with reservations]
by: Ian Roberts, et al.
Published: (2018-09-01)

Antifibrinolytic drugs for acute traumatic injury
by: Ian Roberts, et al.

A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury
by: Jack Williams, et al.
Published: (2022-05-01)

Natural bradykinin antagonists
by: João B. Calixto, et al.
Published: (1991-01-01)

The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
by: Allen Elizabeth, et al.
Published: (2010-04-01)

Current Clinical Trials in Traumatic Brain Injury
by: Zubair Ahmed
Published: (2022-04-01)

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury, a nested randomised, placebo-controlled trial
by: P Perel, et al.
Published: (2012-03-01)

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
by: Shoumitro Deb, et al.
Published: (2020-09-01)

Antifibrinolytic agents in traumatic haemorrhage.
by: Tim Coats, et al.
Published: (2005-03-01)

Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials.
by: David A Kolin, et al.
Published: (2020-01-01)

ACE inhibitors, angiotensin receptor antagonists and bradykinin
by: Michael Schachter
Published: (2000-03-01)

Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury
by: sajad shafiee, et al.
Published: (2022-01-01)

Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results
by: Raoul Mansukhani, et al.
Published: (2020-07-01)

Rehabilitation and causes of premature mortality in patients with traumatic brain injury--reply.
by: Fazel, S, et al.
Published: (2014)

The BALANCE trial - Authors' reply
by: Geddes, J, et al.
Published: (2010)

Brain age in chronic traumatic brain injury
by: Gershon Spitz, et al.
Published: (2022-01-01)

Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial [version 2; peer review: 2 approved]
by: Ian Roberts, et al.
Published: (2023-08-01)

Between-centre differences and treatment effects in randomized controlled trials: A case study in traumatic brain injury
by: Roberts Ian, et al.
Published: (2011-08-01)

Systematic review of prognostic models in traumatic brain injury
by: Roberts Ian, et al.
Published: (2006-11-01)

Managing clinical trials
by: Kenyon Sara, et al.
Published: (2010-07-01)

From trial to practice Authors' reply
by: Glasziou, P, et al.
Published: (2010)

European society of intensive care medicine study of therapeutic hypothermia (32-35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial)
by: Stocchetti Nino, et al.
Published: (2011-01-01)

RETRACTED: Hyperbaric oxygen for severe traumatic brain injury: a randomized trial
by: Xianliang Zhong, et al.
Published: (2020-10-01)

Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury
by: AK Mahapatra, et al.
Published: (2008-06-01)

Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials
by: Celia Bonilla, et al.
Published: (2021-06-01)

The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial
by: Abolfazl Jokar, et al.
Published: (2017-02-01)

Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury
by: Robert Vink, et al.
Published: (2024-03-01)

Traumatic brain injury
by: Marijana Matas, et al.
Published: (2023-01-01)

Traumatic Brain Injury
by: Michael Galgano, et al.
Published: (2017-07-01)

Traumatic brain injury
by: G. Onose, et al.
Published: (2011-03-01)

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS)
by: Daniel Francis McAuley, et al.
Published: (2023-11-01)

Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group
by: Bahram Aminmansour, et al.
Published: (2012-01-01)

Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial
by: Inge A. M. van Erp, et al.
Published: (2021-12-01)

Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury
by: Rosemary Dubiel, et al.
Published: (2018-09-01)

PACE trial authors' reply to letter by Kindlon.
by: White, P, et al.
Published: (2013)